Takao Miwa

56PUBLICATIONS
59CO-AUTHORS
Medical biochemistry - lipidsPredictive and prognostic markersEpidemiological modellingCardiology (incl. cardiovascular diseases)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Aug 03, 2026
Letter: Major Adverse Outcomes in Steatotic Liver Disease Subtypes-From Etiological Classification to Biological Phenotyping: Authors' Reply.

|May 15, 2026
Letter: Disease Stage and Absolute Risk in Evaluating the Branched-Chain Amino Acid to Tyrosine Ratio in Cirrhosis. Authors' Reply.

|May 12, 2026
Subtype Differences in Major Adverse Liver Outcomes and Cardiovascular Events and Mortality in Steatotic Liver Disease: A UK Biobank Analysis.

|May 08, 2026
Covert hepatic encephalopathy as a multi-organ syndrome: the gut-liver-muscle-brain axis, diagnosis, treatment, and multidisciplinary care.

|May 06, 2026
Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled Trial.

|Apr 15, 2026
Subcutaneous Adipose Tissue Accumulation is Associated With an Improved Prognosis in Patients With Hepatocellular Carcinoma.

Kenji Imai, Koji Takai, Mikita Oi

Pageof 10

Frequent Collaborators

27 joint publications

Masahito Shimizu

18 joint publications

Shinji Unome

17 joint publications

Tatsunori Hanai

10 joint publications

Yohei Shirakami